Oracea Doxycycline 40mg Modified-Release Capsules from Japan
Oracea brand 40mg doxycycline capsules with modified-release for anti-inflammatory treatment of rosacea, not antibacterial dosing. Still under HTS 3004.20.00.65 as it contains doxycycline salts in measured retail doses for therapeutic use.
Duty Rate — Japan → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Include bioequivalence data for modified-release formulations
• Label as sub-antimicrobial dose if applicable to match therapeutic claims
• Ensure packaging prevents moisture degradation common in doxycycline